glp-1 patches safety patch Things to Know About GLP-1 GLP-1 Patches: Safety, Efficacy &
Description
July 2024: A study linking patients with type 2 diabetes who were taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) to an increased risk of a rare and serious eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION)
Regular monitoring, ongoing support, and willingness to adjust strategies based on individual response optimize outcomes
However, exact numbers can depend on various factors, including body type, age and how well one sticks to the diet
10.1210/jc.86.9.4382 92
A qualitative study: Barriers and facilitators to health care access for individuals with psychiatric disabilities Psychiatric Rehabilitation Journal
